The Sickle Cell Clinical Trials Network: One Year In
The Hematologist Editor-in-Chief, Dr. Laura Michaelis, spoke with Drs. Charles Abrams and Sophie Lanzkron about a groundbreaking ASH initiative started approximate
Is Double-hit Diffuse Large B-cell Lymphoma More Common Than We Think?
Dr. Kahl studies the biologic underpinnings of a new entity that does not meet the classical definition of double-hit (DH) DLBCL but has gene expression signatures and clin
Dr. Julie Kanter, one of the Society's most vocal sickle cell disease (SCD) advocates, spoke with The Hematologist about her success speaking out on behalf of patients with SCD.
ASH Committee on Practice Chair Dr. Joseph Alvarnas discusses issues faced by practicing hematologists and why it is important for physicians to have their voices heard by policymakers.
ASH Government Affairs Committee Chair, Dr. Alan Rosmarin, stresses the importance of becoming involved in ASH's advocacy efforts.
Dr. Jason Westin spoke to the Grassroots Network at the 2018 Grassroots Network Lunch in San Diego about his experience running for Congress and urged them to advocate for their patients and science.
ASH Leadership Institute participants Drs. Alexis Leonard and Deepa Manwani discuss their time in our nation's capital advocating for hematology.
Dr. Roy Silverstein talks about his experience meeting with U.S. Department of Health and Human Services leaders on July 12, 2018, to discuss the Society's work and mission in the area of sickle cell disease.
Dr. Michaelis has a conversation with Chair of the ASH Committee on Training Dr. Alison Loren about how the idea to redesign Trainee Day came about and what to expect at ASH-a-Palooza.
New Director of the Sickle Cell Disease Clinical Trials Network Dr. Charles Chesson answers questions about his role and the direction of the network in the near future.
TRTH 2015 co-directors Drs. Jean Soulier and David M. Bodine talk about the program that provides expert training to a select group of 20 trainees from Europe and North America engaged in research into the mechanisms of hematologic disorders and experimental treatments.
Dr. David Bodine provides insight into the ASH Bridge Grant's origins, future, and current impact on hematology.
July-August 2019Volume 16, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology